Adrenal mass evaluation in patients with lung carcinoma: A cost- effectiveness analysis

American Journal of Roentgenology

Volumn 174, Issue 4, 2000, Pages 1033-1039

  Remer, Erick M ^a   Obuchowski, Nancy ^a   Ellis, James D ^a   Rice, Thomas W ^a   Adelstein, David J ^a   Baker, Mark E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX ADENOMA; ADRENAL TUMOR; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; HUMAN; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; TUMOR BIOPSY;

EID: 0034127426     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.174.4.1741033     Document Type: Article

References (36)

1. Shuman WP, Moss AA. The adrenal glands. In: Moss AA, Gamsu G, Genant HK, eds. Computed tomography of the body, 2nd ed. Philadelphia: Saunders, 1992:1045-1056
2. Oliver TW Jr, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology 1984;153:217-218
3. Welch TJ, Sheedy PF II, Stephens DH, Johnson CM, Swenson SJ. Percutaneous adrenal biopsy: review of 10-year experience. Radiology 1994;193: 341-344
4. Mody MK, Kazerooni EA, Korobkin M. Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 1995;19:434-439
5. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-418
6. van Erkel AR, van Gils APG, Lequin M, Kruitwagen C, Bloem JL, Falke THM, CT and MR distinction of adenomas and nonadenomas of the adrenal glands. J Comput Assist Tomogr 1994;18: 432-438
7. Singer AA, Obuchowski NA, Einstein DM, Paushter DM. Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 1994;61:200-205
8. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996;166:531-536
9. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351
10. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1993;186: 705-709
11. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995;165:91-95
12. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995;197:411-418
13. McNicholas MMJ, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR 1995;165:1453-1459
14. Schwartz LH, Panicek DM, Doyle MV, et al. Comparison of two algorithms and their associated charges when evaluating adrenal masses in patients with malignancies. AJR 1997;168:1575-1578
15. Dwamena BA, Kloos RT, Fendrick AM, et al. Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. Nucl Med 1998;39:707-712
16. Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer. J Clin Oncol 1995;13:2166-217
17. Sandler MA, Pearlberg JL, Madrazo BL, Gitschlag KF, Gross SC. Computed tomographic evaluation of the adrenal gland in the preoperative assessment of bronchogenic carcinoma. Radiology 1982;145: 733-736
18. Pagani JJ. Non-small cell lung carcinoma adrenal metastases: computed tomography and percutaneous needle biopsy in their diagnosis. Cancer 1984; 53:1058-60
19. Salvatierra A, Baamonde C, Llamas JM, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990;97:1052-1058
20. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE. Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 1993;187:715-718
21. Malenka DJ, Colice GL, Jacobs C, Beck JR. Mediastinal staging in non-small-cell lung cancer. Med Decis Making 1989;9:231-242
22. Damhuis RA, Schutte PR. Resectior rates and postoperative mortality in 7,899 patients with lung cancer. Euro Respir J 1996;9:7-10
23. Vrdoljak E, Mise K, Sapunar D, Rozga A, Marusic M. Survival analysis of untreated patients with non-small-cell lung cancer. Chest 1994;106:1797-1800
24. Bunn PA Jr. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Semin Oncol 1994;21[suppl 6]:49-59
25. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the Lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles & practice of oncology, 4th ed. Philadelphia: Lippincott, 1993:673-712
26. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989;262:2879-2886
27. Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness in oncology: rational allocation of cancer care resources. J Natl Cancer Inst 1993; 85:1460-1474
28. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996;200:749-752
29. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200:743-747
30. Ries LA. Influence of extent of disease, histology, and demographic factors on lung cancel survival in the SEER population-based data. Semin Surg Oncol 1994;10:21-30
31. Jaakkimainen L, Goodwin PJ, Pater J, Warde P, Murray N, Rapp E. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol 1990;8:1301-1309
32. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996;200:737-742
33. Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997;202:693-696
34. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;194:131-134
35. Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR 1997;168:1357-1360
36. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-390